CN Stock MarketDetailed Quotes

Hunan Fangsheng Pharmaceutical (603998)

Watchlist
  • 10.54
  • 0.000.00%
Trading May 19 10:16 CST
4.63BMarket Cap15.10P/E (TTM)

Hunan Fangsheng Pharmaceutical (603998) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
心脑血管疾病用药633.2M36.26%
骨骼肌肉系统用药393.76M22.55%
Other254.05M14.55%
Children's medication162.11M9.28%
Respiratory system medication112.44M6.44%
抗感染用药72.78M4.17%
妇科疾病用药60.69M3.48%
Other business57.42M3.29%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing1.62B92.85%
医疗业务及其他67.4M3.86%
Other business57.42M3.29%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region385.9M22.10%
Hunan377.97M21.64%
Central China325.38M18.63%
Southwest area241.43M13.82%
South China176.9M10.13%
North China176.42M10.10%
Northwest region62.44M3.58%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More